Displaying drugs 14126 - 14150 of 15469 in total
Belagenpumatucel-L (NCI H-520)
Investigational
Belagenpumatucel-L (RH 2)
Investigational
PAT-SM6
Investigational
SCH-58500
SCH-58500 is a recombinant replication-deficient adenovirus vector carrying the human p53 gene.
Investigational
VXM01
Investigational
KAHR-102
KAHR-102 is a dual signaling protein fusing cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) to the Fas-ligand (FasL).
Investigational
ERC-1671
Investigational
pM-81
Investigational
Mecbotamab vedotin
Mecbotamab vedotin is an anti-Axl humanized monoclonal antibody conjugated to monomethyl auristatin E using a cleavable linker (CAB-Axl-ADC).
Investigational
MK-0482
MK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT) 3.
Investigational
MK-4830
MK-4830 is a monoclonal antibody that targets the myeloid-specific immunoglobulin-like transcript (ILT) 4 receptor.
Investigational
Therapeutic allogeneic lymphocytes
Investigational
ETBX-011
ETBX-011 is a cancer vaccine used to treat patients with cancers that express carcinoembryonic antigen (CEA).
Investigational
Interleukin-15, human recombinant
Investigational
Odetiglucan
Investigational
Incomplete Freund's adjuvant
Investigational
Barecetamab
Investigational
BI-765063
BI-765063 is a humanized IgG4 monoclonal antibody antagonist of signal regulatory protein α (SIRPα).
Investigational
Vidutolimod
Vidutolimod is a Toll-like receptor 9 (TLR9) agonist. It is an investigational cancer vaccine.
Investigational
RO7502175
Investigational
UCPVax
Investigational
Sirexatamab
Investigational
GEN-001
Investigational
Displaying drugs 14126 - 14150 of 15469 in total